NEW YORK – While recent actions by the federal government directed at nursing homes could increase the need for SARS-CoV-2 tests to nearly unheard-of volumes, the industry said it is ready and will meet the anticipated demand.
Specifically, the developers and manufacturers of rapid antigen tests for the coronavirus said that they are prepared for what could be an enormous demand for such tests, which detect protein antigens, rather than viral antigens as with PCR-based tests.